Journal
NATURE REVIEWS ENDOCRINOLOGY
Volume 5, Issue 5, Pages 253-261Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrendo.2009.23
Keywords
-
Categories
Funding
- US National Institute of Health [P01 AG-11412, R01 HL-075079, P60 DK-20595, R01 DK-0716960, R01 HL-075025, M01 RR000055]
- US Department of Defense [W81XWH-07-2-0071]
- AASM/Pfizer
- Belgian 'Fonds de la Recherche Scientifique Medicale' [FRSM-3.4583.02]
- 'Fonds National de la Recherche Scientifique' (FNRS)
- 'CARE Foundation'
- INSERM [U628]
- Claude Bernard University of Lyon, France
- NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000055] Funding Source: NIH RePORTER
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075025, R01HL075079] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071696, P60DK020595] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON AGING [P01AG011412] Funding Source: NIH RePORTER
Ask authors/readers for more resources
The importance of sleep to hormones and glucose metabolism was first documented more than four decades ago. since then, sleep curtailment has become an endemic behavior in modern society. in addition, the prevalence of sleep disorders, particularly obstructive sleep apnea (OsA), has increased. OsA is very common in endocrine and metabolic disorders, but often remains undiagnosed. This review summarizes the laboratory and epidemiologic evidence that suggests how sleep loss, either behavioral or disease-related, and poor quality of sleep might promote the development of obesity and diabetes mellitus, and exacerbate existing endocrine conditions. Treatment of sleep disorders has the potential to improve glucose metabolism and energy balance. screening for habitual sleep patterns and OsA might be critically important for patients with endocrine and metabolic disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available